{"canonical":"https://abierto.us/opportunities/ht942626ce018","key":"HT942626CE018","url":"https://abierto.us/opportunities/ht942626ce018","title":"Antibacterial Nanoparticles Therapeutic (ANT) Study","solicitation_number":"HT9426-26-C-E018","notice_type":"a","open":false,"response_deadline":null,"first_posted":"2026-08-19","last_posted":"2026-08-19","department":"DEPT OF DEFENSE","subagency":"DEFENSE HEALTH AGENCY (DHA)","office":"DEFENSE HEALTH AGENCY","naics":"541713","psc":"AN13","set_aside":null,"place_state":"MD","winner":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame","award_amount":"295460.00","publications":[{"notice_id":"754a19a558d64976a1f2e93870913a09","title":"Antibacterial Nanoparticles Therapeutic (ANT) Study","solicitation_number":"HT9426-26-C-E018","notice_type":"a","base_type":"s","posted":"2026-08-19","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2026-09-03","award_number":"HT9426-26-C-E018","awardee_name":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame","amount":"295460.00","link_sam":"https://sam.gov/workspace/contract/opp/754a19a558d64976a1f2e93870913a09/view","enriched":false,"history":[]}],"latest_notice_id":"754a19a558d64976a1f2e93870913a09","first_type":"a","notices":[{"award":{"date":"2026-08-19","amount":"295460.00","number":"HT9426-26-C-E018","awardee":{"raw":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame IN 46556 USA","name":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame","location":{"zip":"46556","state":{"code":"IN"},"country":{"code":"USA"}}}},"dates":{"posted":"2026-08-19","award_date":"2026-08-19"},"links":{"sam":"https://sam.gov/workspace/contract/opp/754a19a558d64976a1f2e93870913a09/view"},"naics":{"codes":["541713"],"primary":"541713"},"title":"Antibacterial Nanoparticles Therapeutic (ANT) Study","agency":{"office":{"code":"HT9426","name":"DEFENSE HEALTH AGENCY"},"subtier":{"code":"97DH","name":"DEFENSE HEALTH AGENCY (DHA)"},"department":{"code":"097","name":"DEPT OF DEFENSE"},"office_address":{"zip":"21702","city":"FORT DETRICK","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2026-09-03","archive_type":"auto15"},"contacts":[{"name":"Linda Hinson","role":"primary","email":"linda.t.hinson.civ@health.mil"},{"name":"Sharew Hailu","role":"secondary","email":"sharew.hailu.civ@health.mil"}],"base_type":{"code":"s","label":"Special Notice"},"notice_id":"754a19a558d64976a1f2e93870913a09","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2026_archived_opportunities.csv","etag":"\"d9374b90a938e9923d910594731b7b57-106\"","fetched_at":"2026-09-16T00:55:27.040971Z","row_sha256":"9898c895da25f2e78c9bdd6f33d765b7aaa4167623160e74679199ac0868022e","last_modified":"2026-09-13T14:50:39Z"},"updated_at":"2026-09-16T00:55:27.040971Z","first_seen_at":"2026-09-16T00:55:27.040971Z"},"description":{"text":"The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.gov’s GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officer’s Representative preformed a technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on sam.gov’s GPE on 14 April 2026, with a closing date of 28 April 2026. No responses were received. Therefore, market research determined a non-commercial FAR RFO Part 13 sole source award to the University of Notre Dame to be in the best interest of the Government.","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"HT9426-26-C-E018","place_of_performance":{"zip":"20910","city":{"name":"Silver Spring"},"state":{"code":"MD"},"country":{"code":"USA"}},"product_service_code":"AN13"}],"due_at":null,"due_date":null,"closes_at":null,"awardable":false,"dept_key":"d-097","dept_name":"DEPT OF DEFENSE","sub_key":"s-97DH","sub_name":"DEFENSE HEALTH AGENCY (DHA)","office_key":"o-HT9426","office_name":"DEFENSE HEALTH AGENCY","state":"MD","country":"USA","winner_key":null,"amount":"295460.00","linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z","principal_notice_id":"754a19a558d64976a1f2e93870913a09","description":{"text":"The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.gov’s GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officer’s Representative preformed a technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on sam.gov’s GPE on 14 April 2026, with a closing date of 28 April 2026. No responses were received. Therefore, market research determined a non-commercial FAR RFO Part 13 sole source award to the University of Notre Dame to be in the best interest of the Government.","html":null,"origin":"extract"},"contacts":[{"name":"Linda Hinson","role":"primary","email":"linda.t.hinson.civ@health.mil"},{"name":"Sharew Hailu","role":"secondary","email":"sharew.hailu.civ@health.mil"}],"place_of_performance":{"zip":"20910","city":{"name":"Silver Spring"},"state":{"code":"MD"},"country":{"code":"USA"}},"office_address":{"zip":"21702","city":"FORT DETRICK","state":"MD","country":"USA"},"naics_codes":["541713"],"award":{"date":"2026-08-19","amount":"295460.00","number":"HT9426-26-C-E018","awardee":{"raw":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame IN 46556 USA","name":"UNIVERSITY OF NOTRE DAME DU LAC Notre Dame","location":{"zip":"46556","state":{"code":"IN"},"country":{"code":"USA"}}}},"attachments":[],"awards":[],"related":[{"key":"HT942626QE058","latest_notice_id":"e3f02eadfc48433ab9f37fbcedae0387","title":"Clinical Blood Processing","solicitation_number":"HT942626QE058","notice_type":"o","first_type":"o","first_posted":"2026-09-10","last_posted":"2026-09-10","notices":1,"due_at":"2026-09-24T15:00:00Z","due_date":"2026-09-24","closes_at":"2026-09-24T15:00:00Z","awardable":true,"open":true,"dept_key":"d-097","dept_name":"DEPT OF DEFENSE","sub_key":"s-97DH","sub_name":"DEFENSE HEALTH AGENCY (DHA)","office_key":"o-HT9426","office_name":"DEFENSE HEALTH AGENCY","naics":"621511","psc":"Q301","set_aside":null,"state":"MD","country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T07:31:38.954589Z"}]}